Enzyme.Myso Introduces Institutional-Grade Options for On-Chain Yield Generation
Enzyme.Myso Introduces Institutional-Grade Options for On-Chain Yield Generation
🎯 DAOs New Yield Secret
Enzyme.Myso is advancing DeFi with institutional-grade on-chain options trading. The platform offers:
- Native on-chain options strategies
- Fully auditable transaction flows
- Infrastructure designed for DAOs and institutions
Real-world implementation: Compound DAO recently integrated covered calls into their treasury strategy using Enzyme.Myso, targeting approximately 15% APY while maintaining controlled risk exposure.
This development signals a shift in how DAOs can optimize idle capital through sophisticated options strategies.
Learn more at Enzyme Finance
Institutional Treasury Management Hits $100B Milestone
On-chain crypto treasuries have reached a significant milestone with **$100 billion in assets** now being managed by institutional-grade firms, according to Cointelegraph. This signals a fundamental shift in treasury management practices, driven by: - Growing institutional demand for transparency - Need for compliance and risk controls - Adoption of tokenized vaults - Implementation of programmable strategies The trend highlights how treasury management has evolved into a strategic imperative for corporates, DAOs, and asset managers. As more organizations move their operations on-chain, the demand for secure, modular, and transparent asset management infrastructure continues to grow.
Tokenized Securities Market Projected to Reach $45T by 2030
Major financial institutions are forecasting significant growth in tokenized assets: - Citi projects tokenized securities market could reach $45T by 2030 - WEF estimates 10% of global GDP could be blockchain-tokenized by 2027 - McKinsey reports shift from pilot to at-scale deployment Key trends expected in next cycle: - Shift to natively tokenized funds - Increased institutional adoption - Integration with DeFi infrastructure - Clearer regulatory framework Traditional finance faces challenges from outdated systems, while tokenized vehicles offer programmability and global accessibility. Enzyme Protocol is positioning to support this transition with native tokenization capabilities. [Learn more about tokenized funds](http://enzyme.finance/use-cases/tokenized-funds)
Tokenized Real-World Assets Hit Major Milestone
Real-world assets (RWAs) tokenized on blockchain have reached a significant milestone, surpassing $10B in Total Value Locked (TVL). This marks a crucial shift in how traditional assets are being brought on-chain. Key developments: - Over $18B in assets now tokenized (excluding stablecoins) - Infrastructure development becoming priority for operational use - Integration possibilities include RWA funds, ETPs, and indices Enzyme Protocol enables users to leverage these tokenized assets within investment strategies, marking a practical step toward mainstream RWA adoption. Learn more about tokenized asset infrastructure: [Chainlink's Guide](https://blog.chain.link/definitive-guide-to-tokenized-assets/)
Enzyme Acquires Myso Finance and Expands to Solana in Major 2024 Growth
Enzyme Protocol marked significant expansion in 2024 with key developments: - Acquired Myso Finance, the leading on-chain covered calls protocol - Invested in Trade Neutral to expand services to Solana ecosystem - Extended protocol to Arbitrum and integrated GMX - Launched first Advanced Automated Loops with Stader Labs - Reached $220M in Assets Under Technology with 1,400+ creations 2025 roadmap focuses on: - Completing Solana integration - Expanding to additional networks - Launching V5 protocol update - Strengthening global infrastructure position The protocol has maintained steady growth since its 2017 launch as Melon Protocol, navigating market cycles while expanding capabilities.